Stablepoint Partners, LLC
Source: SEC Form 13F · as of Mar 2026Stablepoint Partners, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $64.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$64.2M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 30,968 | $10.9M |
| MRKMerck & Co., Inc. | 66,669 | $8.0M |
| JNJJOHNSON & JOHNSON | 29,757 | $7.3M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 108,849 | $6.0M |
| PFEPFIZER INC | 198,246 | $5.6M |
| ABBVAbbVie Inc. | 21,886 | $4.8M |
| GILDGILEAD SCIENCES, INC. | 23,221 | $3.2M |
| LLYELI LILLY & Co | 3,293 | $3.0M |
| DGXQuest Diagnostics Incorporated | 14,626 | $2.9M |
| ABTABBOTT LABORATORIES | 21,583 | $2.2M |
| AZNASTRAZENECA PLC | 10,742 | $2.1M |
| MCKMcKesson Corporation | 2,238 | $1.9M |
| SNYSanofi | 33,412 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,951 | $1.3M |
| PMPhilip Morris International Inc | 7,518 | $1.2M |
| NVONovo Nordisk A/S | 25,250 | $928K |
| NVSNovartis AG | 4,530 | $692K |
| GMOptec International, Inc. | 5,933 | $442K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.